Immunomodulatory therapies (IMT) (e.g., corticosteroids, IL‐6 inhibitors, GM‐CSF inhibitors, methotrexate, calcineurin inhibitors, and antitumor necrosis factor agents) have been used to treat the hyperinflammatory response seen in severe or critical COVID-19 [101]. Here, CSF2 is linked to COVID-19.